Mallinckrodt competitors

Zippia score 4.8

Mallinckrodt main competitors are Allergan plc, Merck, and Cadence Pharmaceuticals.

Competitor Summary. See how Mallinckrodt compares to its main competitors:

Johnson & Johnson has the most employees (134,500).
Employees at Allergan plc earn more than most of the competitors, with an average yearly salary of $99,508.
The oldest company is Johnson & Johnson, founded in 1886.

Work at Mallinckrodt?

Share your experience

Mallinckrodt vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Mallinckrodt	1867	4.8	Hazelwood, MO	5	$1.0B	3,400
Johnson & Johnson	1886	4.7	New Brunswick, NJ	26	$88.8B	134,500
Merck	1891	4.6	Kenilworth, NJ	31	$64.2B	74,000
NeurogesX	1998	4.2	San Mateo, CA	1	$11.5M	20
Hospira	2004	4.8	Lake Forest, IL	1	$4.5B	19,000
ALZA Corporation	1968	4.3	Vacaville, CA	1	$200.0M	10,000
Baxter International	1931	4.2	Deerfield, IL	6	$10.6B	48,000
Assured Pharmacy Inc.	1999	3.7	Frisco, TX	1	$5.2M	10
Cardinal Health	1971	4.4	Dublin, OH	38	$226.8B	48,000
Allergan plc	1948	4.8	Irvine, CA	1	$7.2B	11,400
Cadence Pharmaceuticals	2004	4.5	San Diego, CA	1	$112.6M	350
Watson Pharma Pvt Ltd	1984	4.9	Parsippany-Troy Hills, NJ	1	$5.9B	21,600
Sigma-Aldrich	1951	4.9	Saint Louis, MO	2	$2.8B	9,600
Par Pharmaceutical Inc	2003	4.9	Spring Valley, NY	4	$260.0M	400
Akorn	1971	4.8	Lake Forest, IL	7	$682.4M	2,227
Mylan	1961	4.8	Canonsburg, PA	2	$11.5B	35,000
Lantheus	1956	4.7	Billerica, MA	3	$1.5B	612
Pharmaceutics International	1994	4.5	Huntingtown, MD	2	$367.8M	1,000
Watson Laboratories	1992	4.4	Corona, CA	1	$37.0M	50
URL Pharma	1946	4.4	Philadelphia, PA	1	$38.0M	211
Aptuit	2004	4.3	Greenwich, CT	1	$100.0M	1,733

Rate how well Mallinckrodt differentiates itself from its competitors.

Mallinckrodt salaries vs competitors

Among Mallinckrodt competitors, employees at Allergan plc earn the most with an average yearly salary of $99,508.

Compare Mallinckrodt salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Mallinckrodt	$61,563	$29.60	-
Johnson & Johnson	$76,686	$36.87	-
Merck	$90,328	$43.43	-
NeurogesX	$64,908	$31.21	-
Hospira	$64,435	$30.98	-
ALZA Corporation	$59,528	$28.62	-

Compare Mallinckrodt job title salaries vs competitors

Company	Highest salary	Hourly salary
Mallinckrodt	$89,098	$42.84
Merck	$107,158	$51.52
Watson Pharma Pvt Ltd	$106,670	$51.28
Hospira	$106,200	$51.06
Assured Pharmacy Inc.	$100,117	$48.13
Baxter International	$98,683	$47.44
Allergan plc	$97,984	$47.11
Johnson & Johnson	$94,110	$45.25
Akorn	$93,515	$44.96
Lantheus	$92,922	$44.67
Sigma-Aldrich	$92,452	$44.45
Mylan	$90,600	$43.56
Watson Laboratories	$90,080	$43.31
Par Pharmaceutical Inc	$89,945	$43.24
URL Pharma	$89,910	$43.23
Pharmaceutics International	$89,600	$43.08
NeurogesX	$89,119	$42.85
Cadence Pharmaceuticals	$88,960	$42.77
ALZA Corporation	$88,292	$42.45
Aptuit	$87,428	$42.03

Do you work at Mallinckrodt?

Does Mallinckrodt effectively differentiate itself from competitors?

Mallinckrodt jobs

Mallinckrodt demographics vs competitors

Compare gender at Mallinckrodt vs competitors

Job title	Male	Female
Merck	54%	46%
Akorn	54%	46%
Cardinal Health	55%	45%
Johnson & Johnson	58%	42%
Baxter International	59%	41%
Mallinckrodt	-	-

Male

Female

100%

75%

50%

25%

25%

50%

75%

100%

Compare race at Mallinckrodt vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Akorn	61%	15%	11%	9%	4%	9.4
Baxter International	57%	19%	9%	11%	4%	9.9
Cardinal Health	59%	17%	11%	10%	4%	9.9
Johnson & Johnson	54%	16%	10%	15%	4%	9.8
Merck	56%	16%	10%	14%	4%	9.8
Hospira	57%	14%	12%	12%	4%	10.0

Mallinckrodt and similar companies CEOs

CEOBio

Douglas S. Boothe

Akorn

C-Level Executive with demonstrated leadership skills and proven business results in Pharmaceuticals (Branded and Generics), Sales, Marketing, Operations, Business Development, R&D/Regulatory.I'm a creative problem-solver, with a track record of outstanding results through professional and interpersonal skills including strategic vision, team development, people management, prioritization, motivation, decisiveness and grit.

Jose E. Almeida

Baxter International

José E. Almeida is a Brazilian businessman. He has served as the chairman and CEO of Baxter International, Inc. since January 2016. He worked for Tyco Healthcare from 1995 to 2002. He was president of Medical Devices division from October 2006 to June 2011. He served as chairman of the board of directors of Covidien since March 2012 and as the president, chief executive officer and a director since July 2011. He became a director of EMC Corporation on Jan 12, 2015 and resigned on October 30, 2015, due to his election as chairman and CEO of Baxter. In 2015, he worked for The Carlyle Group as an Operating Executive in the Global Healthcare group.

Michael C. Kaufmann

Cardinal Health

Joaquin Duato

Johnson & Johnson

Mary Anne Heino

Lantheus

Mary Anne Hein is a President & CEO at LANTHEUS HOLDINGS, INC..

Robert M. Davis

Merck

Robert M. Davis is corporate vice president and president of Baxter's Medical Products business. In this position, Davis oversees a range of products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease. Davis took on his current role in October 2010. Prior to this role, Davis served as corporate vice president and president of Baxter's Renal business. He served as corporate vice president and chief financial officer from 2006 through May 2010, and as treasurer from 2004 through 2006. Davis joined Baxter as treasurer in November 2004 from Eli Lilly and Company, where he served in numerous positions of increasing responsibility over 14 years. Davis currently serves on the Board of Trustees for Rush University Medical Center and also serves as a member of the Finance Committee. He also is a member of the Board of Directors of AdvaMed.

Satya Chava

Aptuit

Satya Chava is a Chief Executive Officer at Aptuit and is based in Greenwich, CT area.

Heather Bresch

Mylan

Heather Manchin Bresch (Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn. In 2015, she was listed as #22 in Fortune magazine's “Most Powerful Women” list.

Brenton L. Saunders

Allergan plc

Robert Delvecchio

Assured Pharmacy Inc.

Mr. DelVecchio contributes over 20 years of financial securities experience to Assured Pharmacy. Mr. DelVecchio was appointed Chief Executive Officer in 2005. Under his leadership Assured Pharmacy's revenue have grown from $900,000 annually to over $15,000,000 in sales annually. Previous to this Mr. DelVecchio founded Brockington Securities in 1994. Brockington Securities is a full service brokerage firm. Mr. DelVecchio started his career in the United States Navy as an anti-submarine warfare operator.